Telithromycin: QT prolongation.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D005060:Europe; D006801:Humans; D048628:Ketolides / Q000009:adverse effects*; D008133:Long QT Syndrome / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents; D048628:Ketolides